About Ischemia Technologies
Ischemia Technologies is a company based in Waltham (United States) founded in 1997 was acquired by Abbott in February 2005. It operates as a B2B. Ischemia Technologies has raised $12.7 million across 3 funding rounds from investors including Plymouth Growth, Abbott Global Point of Care and Goodman. Ischemia Technologies operates in a competitive market with competitors including Conavi, Infraredx, Ionetix, Acarix and Cleveland HeartLab, among others.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.7 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Plymouth Growth
& 2 more
-
Employee Count
Not available
-
Acquired by
Abbott
(Feb 14, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ischemia Technologies
Ischemia Technologies has successfully raised a total of $12.7M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ischemia Technologies
Ischemia Technologies has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Plymouth Growth, Abbott Global Point of Care and Goodman.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech & offline focused VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Rapid diagnostics products and solutions for point-of-care testing are provided.
|
Locked | Locked | Locked |
Investor details for Ischemia Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ischemia Technologies
Investment portfolio details for Ischemia Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ischemia Technologies
Detailed financials for Ischemia Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ischemia Technologies Comparisons
Peer comparison for Ischemia Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ischemia Technologies
Ischemia Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Infraredx, Ionetix, Acarix and Cleveland HeartLab, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| Locked | Locked | Locked |
Coronary imaging and plaque detection system
|
|
| Locked | Locked | Locked |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| Locked | Locked | Locked |
A screening device for acoustic coronary artery diseases is provided.
|
|
| Locked | Locked | Locked |
Cardiovascular biomarkers are utilized for disease prevention and management.
|
|
| Locked | Locked | Locked |
Apo J-Glyc biomarker is commercialized for cardiac ischemia diagnosis.
|
Detailed competitors of Ischemia Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ischemia Technologies
Complete news archive for Ischemia Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ischemia Technologies
Ischemia Technologies was founded in 1997 and raised its 1st funding round 3 years after it was founded.
Ischemia Technologies is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Ischemia Technologies is a funded company, having raised a total of $12.7M across 3 funding rounds to date.
Ischemia Technologies operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, diagnostic testing, and in vitro diagnostics. Develops, manufactures, and markets in vitro diagnostic tests for detecting cardiac ischemia. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Ischemia Technologies has 3 investors. Key investors include Plymouth Growth, Abbott Global Point of Care, and Goodman.